Approximately 80% of pediatric T-ALL patients exhibit elevated levels of β-catenin compared to healthy controls, resulting in abnormal activation of β-catenin-dependent genes such as survivin, c-Myc, TCF1, and LEF [98]. The gene discussed is BIRC5; the disease is acute lymphoblastic leukemia.